Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Cognex (CGNX)

Cognex Q2 revenue rises 4% to $249 million; diluted EPS $0.24 vs. $0.21 a year earlier

Positive Impact 3 of 5 earnings Written later

Cognex reported second-quarter 2025 revenue of $249 million, up 4% from a year earlier, and GAAP diluted earnings of $0.24 per share, up from $0.21. It also issued third-quarter 2025 guidance of $245 million to $265 million in revenue and $0.24 to $0.29 in adjusted diluted EPS, and declared a quarterly dividend of $0.08 per share.

Key points

  • Q2 2025 revenue was $249 million vs. $239 million in Q2 2024; adjusted diluted EPS was $0.25 vs. $0.23.
  • GAAP gross margin fell to 67.4% from 69.6% a year earlier, which the company attributed mainly to less favorable industry mix and, to a lesser extent, tariffs.
  • Q3 2025 guidance ranges are $245 million to $265 million in revenue and $0.24 to $0.29 in adjusted diluted EPS, excluding a one-time partnership benefit of $8 million to $14 million in revenue.
  • Cognex declared a quarterly cash dividend of $0.08 per share, payable August 28, 2025, to holders of record on August 14, 2025.

The filing

CompanyCognex (CGNX)
Form8-K, current report
Filed with the SECJul 30, 2025, 4:34 PM ET
Accession number0000851205-25-000050

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.